Stimulus Plans, Drug Trials, and the New Normal

24 Apr 2020 · 57 min
56:39

Keith Robinson and James Dwiggins review COVID-19 trends, testing gaps, and flawed early antibody studies from Santa Clara and LA. They warn against hydroxychloroquine after an NIH trial showed higher mortality, note 70 vaccine candidates in development, and discuss $480B in new stimulus funding as unemployment hits 26.5 million claims.

Chapters

More from Steven

youtube.com

Money Creates Options

1y ago
youtube.com

The Importance of Relationships in Life

1y ago
youtube.com

The Significance of Personal Stories in Marketing

1y ago
youtube.com

Profit & Greed Are Not the Same

1y ago
youtube.com

First Day

1y ago
youtube.com

The Coffee Bean Metaphor Explained

1y ago
youtube.com

Haters in Life

1y ago
youtube.com

Humans Over Houses

1y ago
youtube.com

Tornado Rebuild

1y ago
youtube.com

I’m Gonna Win

1y ago
youtube.com

One Day or Day One

1y ago
See all content